Dear study participants, I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study. While I always enjoy speaking with study participants, I had very mixed emotions about this conversation, because I was discussing her KRAS-variant results with her – and […]